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Excellence (NICE) guidelines. Multivariable logistic regression was performed to 
examine the association between non-indication based PPI use and various patient 
and physician-level characteristics using 2008-2010 NAMCS data. RESULTS: The 
use of PPIs increased from 5.29% patient visits in 2002 to 11.82% in 2010 (p< .0001). 
Prescription of PPI without an appropriate indication by primary care physicians 
(54.26% to 48.84%), medical specialists (35.21% to 35.62%) and surgeons (10.52% 
to 15.53%) did not change significantly between 2005-2010 (p= 0.55). Additionally, 
80.12% of patient visits involved PPI prescriptions without an appropriate indi-
cation. Results of multivariable logistic regression revealed that, patients with 
more than 3 chronic conditions were significantly more likely to be prescribed 
a PPI without an appropriate indication as compared to patient visits without 
a chronic condition (Odds Ratio (OR) = 2.49, 95% Confidence Interval (CI): 1.26-
4.94). CONCLUSIONS: PPI use among the elderly increased significantly over the 
study period, with 8 out of 10 patient visits involving PPI prescriptions without an 
appropriate indication. Additionally, the study found no change in PPI prescribing 
trend across physician specialties. These findings suggest the need to improve 
quality of PPI prescribing in the vulnerable elderly population.
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OBJECTIVES: to estimate the tangible savings generated when there is a joint 
effort between Pharmacist and Physician METHODS: observational descriptive 
study. Population: patient records belonging to an IPS Bogota, diagnosed with 
Osteoporosis in parenteral drug therapy with bisphosphonates (Zoledronic Acid 
5mg Ibandronic Acid 3mg). Observation period: June 2012 to June 2013 (n= 161). The 
Pharmacist identified patients with non-pertinence to parenteral bisphosphonate. 
Non-pertinence was defined when: the patients had osteopenia (no additional risk 
factors), had renal function < 35 ml/min, no previous scaling with oral medications 
and when were men with diagnosis of osteoporosis. Finally, the Physician defined 
the behavior to follow (changing drug therapy). Analysis: were used absolute and 
relative frequencies, measures central tendency and dispersion. Treatment direct 
costs were quantified before and after assessment by the Pharmacist and the 
Physician. The statistical software SPSS 21 license under the CES University was 
used. RESULTS: pharmacist non-pertinence identified in 34% (54/161) of patients, 
of which, the Physician agreed in 70% of cases (38/54). The 39% of patients switched 
to oral bisphosphonates (Calcium Alendronate 70mg, Strontium Ranelate 2mg, 
Risedronate 35mg), 40% Calcium and Vitamin D3 and 21% left without medication. 
Given that patients were pretreated with Zoledronic Acid 5mg (25/38) or Ibandronic 
Acid 3mg (13/38), this conduct involved a decreased 18% a year later, with savings/
year $ 9,164 (considering only the value of the drugs). CONCLUSIONS: the joint 
work between Pharmacist and Physician showed an important saving in rational 
use of medicines.
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OBJECTIVES: To estimate the incidence of polypharmacy and its strength of asso-
ciation with respect to medication regimen among patients (pediatric and adults) 
visiting ED of a tertiary care hospital in Karachi Pakistan. METHODS: Retrospective 
data was collected of all patients, who visited the Emergency Department (ED) of 
Aga Khan University Hospital, Karachi (AKUH) during January, 2012 to December, 
2012. The detailed clinical records on medication prescribing from admission 
through discharge of all patients was reviewed. RESULTS: Total 51,000 patients 
visited ED during January 2012 till December 2012, out of those polypharmacy 
was common in 40% of patients. Male were 56.6%(9,837) while 43.4% (7,553) were 
females. Peadiatric patients were 17.9% (3,145) while 79% (14,279) were adults. The 
most common triage category for patients was P3 with 37.2% (6,483). Most of these 
patients were those who were recommended admission in other wards 59.6% 
(10,146), 26.5% (4,514) discharged patients and 9% (1,536) leave against medical 
advice (LAMA) patients. CONCLUSIONS: The perils and problems associated with 
Poly pharmacy are a subject of interest as polypharmacy was significant finding 
among all ED patients. The results from this study serves as a baseline to iden-
tifying the drug- related problems among EP and could helpful for pharmacists 
and physicians to develop and implement strategy for risk management in ter-
tiary care hospital. keywords: Polypharmacy, Emergency Department, Emergency 
patients.
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OBJECTIVES: Low-cost generic drug programs (LCGPs) offer an affordable way for 
individuals to obtain a wide variety of prescription drugs, but they may lead to 
exposure misclassification in administrative claims datasets. This study sought to 
assess the prevalence and determinants of LCGP use in a privately-insured adult 
population. METHODS: This study relied on data from the Medical Expenditure 
Panel Survey from 2005 – 2011. LCGP use was defined by two stipulations 1) The 
total cost of the drug was paid out of pocket and 2) The cost of the drug exactly 
matched the cost of an LCGP program. Demographics of LCGP users and non-
users were compared. A multivariable logistic model was estimated to identify 
the determinant variables associated with LCGP use. RESULTS: Of the total study 
among the youngest societies in the developed world. Further efforts are required 
to reduce the substantial CHF burden.
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OBJECTIVES: U.S. healthcare spending on high-cost biologics has escalated over the 
past decade. The Biologics Price Competition and Innovation Act allows for biosimi-
lar products in the United States, which will be lower-cost alternatives to reference 
biologics. This study explored payer attitudes to the reimbursement and adoption 
of biosimilars in the United States. METHODS: Some 61 U.S. medical or phar-
macy directors at managed care organizations (MCOs) were surveyed during 2014 
regarding their expectations for biosimilar reimbursement. RESULTS: Respondents 
indicate that MCOs expect biosimilars to offer a significant discount to the refer-
ence brand to secure reimbursement. A mean discount of 23-24% is considered 
adequate for reimbursement, while 33-34% is deemed necessary for preferential 
reimbursement to the reference brand. Rapid formulary inclusion of biosimilars is 
expected, with 79% of respondents indicating formulary inclusion within 12 months 
of launch. Widespread reimbursement of biosimilars in extrapolated indications is, 
however, uncertain, with only 34% of respondents reporting that their MCO would 
unconditionally reimburse a biosimilar under such circumstances. Payers expect 
to employ various strategies to promote biosimilar uptake, from favorable tiering 
to step-therapy requiring biosimilar prescribing prior to the reference brand. The 
most conducive uptake strategies are expected for products with deep discounts. 
In addition, payers will run educational campaigns for physicians. However, ≥ 80% 
of respondents say their biosimilar approach will likely be influenced by thought-
leading physicians and medical associations. Furthermore, widespread “grandfa-
thering” is expected, i.e. continuation of the reference brand in responsive/stable 
patients. CONCLUSIONS: U.S. payers will preferentially promote biosimilars over 
reference brands using various demand- and supply-side measures, so long as bio-
similars meet their discount expectations and have clinical stakeholder buy-in. 
Payers clearly seek to realize the cost savings biosimilars offer; however, tendency 
to seek clinical stakeholder buy-in, coupled with likelihood of extensive “grand-
fathering”, indicates some need for more robust evidence of cost-effectiveness.
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OBJECTIVES: Medical specialists have an essential role in promotion of generic 
medicines. However, misconceptions and negative perceptions about generic medi-
cines among them could be a major barrier to utilization of generic medicines. 
Therefore, the aim of this study was to explore their knowledge, perceptions and 
views about generic medicines. METHODS: A qualitative methodology was adopted 
in this study. A qualitative descriptive (QD) study with phenomenology overtones 
was the research strategy. Face-to-face semi-structured interviews were conducted 
with a purposive sample of medical specialists until saturation of data was achieved. 
The interviews were audio taped and transcribed verbatim. Then, the subsequent 
transcripts were analysed using thematic analysis. The themes were generated 
using both deductive (theoretical) and inductive coding. To ensure reliability of data 
analysis, peer review and independent analysis of the data was done. RESULTS: Five 
major themes were identified: (1) factors affecting specialists’ prescribing practice 
with regards to generic medicines and original brand medicines, (2) specialists’ per-
ceptions of efficacy, safety and quality of generic medicines, (3) specialists’ knowl-
edge and confidence with Malaysian generic regulatory approval system, (4) drug 
information sources used by the specialists and (5) international non-proprietary 
name (INN) prescribing. CONCLUSIONS: The study findings showed that several 
factors influenced prescribing decision with regards to the brands of the medicines 
including familiarity and experience with generic medicines, medical and clinical 
condition of the patient, availability of the medicine brand in the hospital and 
department financial allocations. Moreover, misconceptions about quality, safety, 
efficacy and bioequivalence of generic medicines were prevalent among the partici-
pants. Furthermore, the participants were not familiar with the Malaysian generic 
medicines approval system. Therefore, medical specialists’ concerns need to be 
addressed. Some recommendations and suggestions were made to improve generic 
medicines utilization in the country.
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OBJECTIVES: The study aimed to examine the utilization patterns of Proton Pump 
Inhibitors (PPIs) among the elderly and the trends in PPI prescribing across phy-
sician specialties in US office-based settings. The study also evaluated various 
patient and physician-level factors affecting non-indication based PPI prescrip-
tion in the above population. METHODS: This retrospective cross-sectional study 
used 2002-2010 National Ambulatory Medical Care Survey (NAMCS) and outpa-
tient portion of the National Hospital Ambulatory Medical Care Survey (NHAMCS) 
data to evaluate PPI utilization patterns based on patient visits. PPI prescribing 
trend among different physician specialties was estimated using 2005-2010 
NAMCS data. Evidence-based indications for PPIs included the US Food and Drug 
Administration (FDA) approved indications and the National Institute of Clinical 
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OBJECTIVES: Kenya’s health sector is faced with challenges of coping with demand 
for care. As part of its strategy of taking essential package for health to citizens, 
its envisioned that level one be linked to healthcare system. The purpose of this 
study was to train CHWs on how to use referral tools to link households to hospi-
tals. The CHWs indicated reasons for referral which was delivered to clinicians at 
the hospitals. METHODS: Quasi -experimental study was carried out in two sub- 
locations in rural Kenya where one hundred CHWs were trained on community-
based-referral and counter-referral model and issued with referral tools. Each was 
assigned 25 households, instructed to regularly visit them in order to identify sick 
persons counsel and refer them to link hospitals. One hundred villages compris-
ing 2209 households with a population of 11,000 people were covered where the 
referral model was implemented. Tally sheets were used to categorize referral 
recommendations. RESULTS: The referral recommendations made by CHWs were 
categorized into seven themes. In total 168 recommendations were made on the 
referral slips, where every CHW made at least 1 to 2 recommendations. The study 
indicated that referral recommendations made for health check up accounted 
for 33% (55/168), referral to attend ANC clinic 16% (27/168), referral for TB and 
malaria treatment 18% (30/168), referral for U5 treatment 11% (19/168), referral 
for delivery 10% (17/168) while referral for immunization/growth monitoring and 
PNC clinic attendance accounted for 6% (10/168) respectively. CONCLUSIONS: 
It was observed that recommendations made by CHWs on the referral forms 
served as a link between them and clinicians at hospitals. The households felt 
connected to hospitals simply by delivering the referral forms bearing CHWs 
comments which clinicians acted upon. It is concluded that in order to ensure 
continuum of care from level one to dispensary ,use of referral tools should be 
encouraged.
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OBJECTIVES: Frequent Emergency Department (ED) visits are associated with 
high healthcare expenditures and reduced quality of care. Socio-economically 
disadvantaged, and individuals with high medical needs, use ED frequently. 
While a common perception is that frequent ED users are more likely to be 
uninsured, in fact, frequent ED users are more likely to have Medicaid or other 
insurance. The objective of this study is to examine the characteristics of the 
frequent ED users among Medicaid beneficiaries residing in West Virginia, Ohio, 
and Maryland. METHODS: A Cross-sectional study design was used. Patient-level 
data such as demographic factors, Medicaid eligibility, visits to primary care pro-
viders (PCP), dental visits and selected chronic conditions were obtained from 
the Medicaid claims for the year 2009. County-level data such as county loca-
tion in metro area were obtained from the Area Health Resource File. The study 
population included adults aged 18-64 years, who had at least one visit to the 
ED, continuously enrolled in fee-for-service, not enrolled in Medicare and alive 
in 2009 (n= 15,779). Adults with 6 or more ED visits were defined as frequent ED 
users. Chi-square tests and logistic regressions were used to determine the unad-
justed and adjusted associations between patient- and county-level factors and 
frequent ED use. RESULTS: In our study population, 8.6% were frequent ED users. 
A higher number of PCP visits was associated with reduction in ED use. In both 
unadjusted and adjusted models, significant differences in frequent ED use were 
observed for gender, eligibility, chronic conditions, and PCP visits. For example, 
in adjusted analyses racial minorities were more likely to have frequent ED use 
(AOR= 1.48, 95%CI= 1.16, 1.90) compared to whites. Women were more likely to have 
frequent ED use compared to men (AOR= 1.19, 95%CI= 1.01, 1.41). CONCLUSIONS: 
Interventions to promote visits to primary care providers may reduce the risk of 
frequent ED use.
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OBJECTIVES: Since October 2011, ACIP has recommended routine HPV vaccina-
tion for males 11-12 years of age with catch-up vaccination for males ages 13-21. 
Well-child visits are a key setting in which to provide HPV vaccination for this 
population. The objectives of this study were to estimate HPV vaccination rates 
among males age 9-21years of age during well-child visits and compare HPV vac-
cination rates during well-child visits in 11-12 year-old males with other vaccines 
recommended for the same age group (Tdap and Meningococcal conjugate vac-
cine (MCV4)). METHODS: A large commercial database (MarketScan®) was used 
for this retrospective cohort study. The study population was males 9-21 years of 
age in 2012 who had well-child visits for assessment of vaccination rates of HPV, 
Tdap, and MCV4 (N= 499,992). RESULTS: In 2012, the well-child visit rate in 9-21 
year-old males was highest among 11-12 year-olds (56.1%) and lowest among 
18-21 year-olds (20.8%). HPV vaccination rates during a well-child visit were 0.5% 
among 9-10 year-olds, 10.1% among 11-12 year-olds, 16.5% among 13-17 year-olds, 
and 13.9% among 18-21 year-olds. HPV vaccination rates in 11-12 year old males 
during well-child visits (10.1%) were much lower than Tdap (32.8%, p< 0.0001) and 
MCV4 (31.1%, p< 0.0001). CONCLUSIONS: The Healthy People 2020 objective for 
HPV vaccination in males is to increase coverage to 80% by age 13–15 years. The 
HPV vaccination rates among study population are not optimal when comparing to 
other mandatory vaccines, especially among 11-12 year-old males. Well-child visits 
currently are missed opportunities and can play an important role to improve 
HPV vaccination in the US.
population (N = 25,288), 44.51% were users. The prevalence of use has increased 
over time, from 28.21% in 2006 to greater than 50% by 2011. On average, users 
were older (45.03 years vs. 41.36), had higher Charlson Comorbidity Indices (0.63 
vs. 0.29), filled more prescriptions per person (33.62 vs. 14.53), and used more 
unique medications (7.33 vs. 3.80). The majority of users were female (59.79%), 
employed (81.56%), married (64.58%), white (76.06%), lived in urban areas (85.59%), 
had prescription drug coverage (96.92%) and fell into the two highest income 
categories (82.38%). Increasing age was a significant predictor of LCGP use as 
individuals 35-54 (OR 1.15, 95% CI 1.07 – 1.23) and 55-64 (OR 1.26, 95% CI 1.16 – 1.36) 
were more likely to be users compared to those aged 18-34. The odds of LCGP use 
increased nearly 20% (OR= 1.19, 95% CI 1.18 – 1.20) for each additional unique 
medication used during an individual’s two-year study period. CONCLUSIONS: 
The prevalence of LCGP use in this privately insured adult population sug-
gests a high potential for exposure misclassification in administrative claims 
datasets.
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OBJECTIVES: To explore the role of ischemic stroke care-pathway on the association 
between education level and one-year survival after admission. METHODS: From 
the Lazio health datawarehouse the incident hospitalizations for ischemic stroke in 
adults during 2011/12 were selected. For each subject the clinical history was defined 
by retrieving previous hospitalizations and drugs prescriptions. The association 
between education level and mortality after stroke was studied for acute (2-30 days 
from admission) and post-acute phase (31-365 days from discharge) using multivari-
ate logistic and Cox models respectively. To identify different scenarios of quality 
care-pathway we considered hospital performance (in terms of 30-days mortality) 
for acute phase; access to rehabilitation and drug treatment post-discharge (number 
of drugs among antihypertensives, antithrombotics, statins) for post-acute phase. 
The probability to survive to acute and post-acute phases according to education 
level and care-pathway scenarios were estimated for a “mean severity” patient 
assuming for this patient the same distribution of comorbidities as observed in the 
cohort. One-year survival probability was calculated as the product of two prob-
abilities. For each scenario one-year probability ratio, university versus elemen-
tary, and its Bayesian confidence intervals [BCI95%] were calculated. RESULTS: We 
identified 9958 patients with ischemic stroke (mean age= 76; 50% male), 53.3% with 
elementary education level and 3.2% with university. The mortality was 14.9% in 
acute phase and 15.7 per 100 person-years in post-acute phase among survivors. 
The adjusted mortality rates in acute and post-acute phase decreased with the 
increase of educational level (RR= 0.90 p-trend< 0.001; HR= 0.85 p-trend< 0.001). For 
the best care-pathway (hospital with high performance, access to rehabilitation, 
use of all three drugs) the one-year probability rate university versus elementary 
was 1.05 [BCI95%= 1.03-1.08], while was 1.22 [BCI95%= 1.12-1.32] for the worst care-
pathway. CONCLUSIONS: The education level was negatively associated with mor-
tality in acute and post-acute phases. The care-pathway reduces but not eliminates 
one-year survival inequity.
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OBJECTIVES: The aim of our study is to assess the utilization of out-patient 
care physiotherapy services related to the Low Back Pain according to gen-
der. METHODS: Data were derived from the countrywide database of Hungarian 
National Health Insurance Fund Administration (NHIFA), based on official reports 
of outpatient care institutes in 2009. The total numbers of different physiotherapy 
services were determined by selecting the reported specific diagnoses codes and 
counting the number treatments provided for that specific diagnosis code. The dif-
ferent types of treatment codes are listed in the chapter of the Guidelines of NHIFA 
for `Physiotherapists, massage-therapists, conductors and other physiotherapy 
practices`. The Low Back Pain was reported according to WHO ICD diagnosis code 
M5450. Population distribution was taken into account on the basis of the data of 
the Central Statistical Office from January 1st 2009. RESULTS: The total number 
of the 151 different physiotherapy services was 433319 cases in male and 803924 
cases in female. The 10 most frequent treatments accounts for 58.74% in male, 
and 57.68% in female of total services. Frequency of the top-10 medical procedures 
were the following in male and female: 1) Ultrasound therapy (10.17%; 9.3%), 2) 
Iontophoresis (8.91%; 7.73%), 3) Passive movement (6.11%; 6.71%), 4) Mid-frequency 
treatment (6.73%; 6%), 5) Muscle strengthening exercises (4.38%; 6.36%), 6) Hand 
Massage (4.88%; 5.08%), 7) Ergo therapy (4.77%; 4.95%), 8) Spinal Mobilization 4.42%; 
4.78%), 9) Diadynamic interference management (4.98%; 4.04%), 10) Training for 
circulation improvement (3.38%; 3.72%). CONCLUSIONS: The list of the 10 most 
frequent types of services reflects to the demand for the combination of active 
and passive exercises. Frequency of the top-10 medical procedures were similar 
in both gender in Hungary.
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